The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

US growth likely to slow to 1.6% this year, hobbled by Trump's trade wars, OECD says. U.S. economic growth will slow to 1.6% this year from 2.8% last year as President ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a ...

Authorities investigate after 8 injured in Colorado attack by man they say yelled 'Free Palestine' ...

Trump orders Walmart to ‘eat the tariffs’ and stop blaming his trade war for rising prices: ‘I’ll be watching’ Tourist Regret: Where People Wish They Hadn’t Gone in 2025 FDA approves Novavax COVID-19 ...

Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...

Moderna Inc. gained U.S. approval for a new COVID vaccine for a narrower group of people, in the latest sign that regulators ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the ...

A temporary exhibit highlighting the woman in the photo, the mystery behind her name and the man who solved it opens in June ...